Normal view MARC view ISBD view

"Use of Treatments After Recovering from Thumb Carpometacarpal Arthritis Surgery.

MedStar author(s):

Giladi, Aviram M

Citation: Plastic & Reconstructive Surgery. 2023 Mar 14PMID: 36912922Institution: Curtis National Hand Center | MedStar Health Research InstituteForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: IN PROCESS -- NOT YET INDEXEDYear: 2023 ISSN:

0032-1052

Name of journal: Plastic and reconstructive surgeryAbstract: BACKGROUND: What treatments patients continue to use more than 1 year after primary thumb carpometacarpal (CMC) arthritis surgery, and how such use relates to patient-reported outcomes, is largely unknown.CONCLUSIONS: Clinically relevant proportions of patients continue to use various treatments a median of 3 years following primary thumb CMC arthritis surgery. Continued use of any treatment is associated with significantly worse patient-reported outcomes for function and pain.LEVEL OF EVIDENCE: IV. Copyright © 2023 by the American Society of Plastic Surgeons.METHODS: We identified patients who had isolated primary trapeziectomy alone or with ligament reconstruction +/- tendon interposition (LR+/-TI) and were 1 to 4 years post-operative. Participants completed a surgical site-focused electronic questionnaire about what treatments they still used. Patient-reported outcomes measures (PROMs) were the Quick Disability of the Arm, Shoulder, and Hand (qDASH) questionnaire and Visual Analog/Numerical Rating Scales (VA/NRS) for current pain, pain with activities, and typical worst pain.RESULTS: One hundred twelve patients met inclusion and exclusion criteria and participated. At a median of 3 years after surgery, over 40% reported current use of at least one treatment for their thumb CMC surgical site, with 22% using more than one treatment. Of those who still used treatments, 48% used over-the-counter medications (OTC), 34% used home or office-based hand therapy, 29% used splinting, 25% used prescription medications, and 4% used corticosteroid injections. One hundred eight participants completed all PROMs. With bivariate analyses we found use of any treatment after recovering from surgery was associated with statistically and clinically significantly worse scores for all measures.All authors: Yousaf IS, Sanghavi KK, Higgins JP, Giladi AM, Means KR JrFiscal year: FY2023 Digital Object Identifier:

https://dx.doi.org/10.1097/PRS.0000000000010393

Date added to catalog: 2023-04-11

Holdings ( 1 )
Title notes ( 6 )

Holdings
Item type	Current library	Collection	Call number	Status	Date due	Barcode
Journal Article	MedStar Authors Catalog	Article		Available

BACKGROUND: What treatments patients continue to use more than 1 year after primary thumb carpometacarpal (CMC) arthritis surgery, and how such use relates to patient-reported outcomes, is largely unknown.

CONCLUSIONS: Clinically relevant proportions of patients continue to use various treatments a median of 3 years following primary thumb CMC arthritis surgery. Continued use of any treatment is associated with significantly worse patient-reported outcomes for function and pain.

METHODS: We identified patients who had isolated primary trapeziectomy alone or with ligament reconstruction +/- tendon interposition (LR+/-TI) and were 1 to 4 years post-operative. Participants completed a surgical site-focused electronic questionnaire about what treatments they still used. Patient-reported outcomes measures (PROMs) were the Quick Disability of the Arm, Shoulder, and Hand (qDASH) questionnaire and Visual Analog/Numerical Rating Scales (VA/NRS) for current pain, pain with activities, and typical worst pain.

RESULTS: One hundred twelve patients met inclusion and exclusion criteria and participated. At a median of 3 years after surgery, over 40% reported current use of at least one treatment for their thumb CMC surgical site, with 22% using more than one treatment. Of those who still used treatments, 48% used over-the-counter medications (OTC), 34% used home or office-based hand therapy, 29% used splinting, 25% used prescription medications, and 4% used corticosteroid injections. One hundred eight participants completed all PROMs. With bivariate analyses we found use of any treatment after recovering from surgery was associated with statistically and clinically significantly worse scores for all measures.

English